Iecithin/sphingomyelin ratios (LSR) and the presence of phosphatidyiglycerol (PG) were determinedfor 735 consecutively received amniotic fluids. Of the 371 fluids with "mature" LSR between 2.0 and 4.5, more than one-third lacked detectable PG. Clinical outcomes for the 305 of the total group that were delivered within 72 h of sampling were also determined. Respiratory distress syndrome (RDS) did not occur in the 239 cases with LSR 2.0, even when, as in 43 instances, PG was not detected. the basis for that report. PG was usually detected by the time the lecithin! sphingomyelin ratio (LSR) indicated maturity, always detected when the LSR exceeded 3.5, and was progressively more concentrated with increases in LSR. Predictive statistics on PG for normal pregnancies were reported by the same group in 1979 (2). They found that a third of the predictions of immaturity by LSR alone were incorrect. If PG was also looked for, the false-immature assessment rate declined to only 7%. Since then, different investigators assessed the degree of coincidence of PG with the LSR and also its clinical predictivity for fetal lung maturation.
the association between amniotic fluid PG and fetal lung maturity, the frequency and predictive value of undetectable amounts of PG in amniotic fluid remain poorly defined.
We assessed the frequency of detection of PG over a range of LSR values by our previously published method in 735 consecutively received amniotic fluid samples (10). We then determined the predictive values of these measurements with this system, individually and in combination, for 305 cases delivered within 72 h of sampling.
Because of the potential confusion caused by variations in analytical procedure between studies, we gave particular attention to correlation of our results with those previously obtained with other methodologies.
To address the important question of the equivalence of the PG in amniotic fluid species detected here to the two-dimensional chromato- 
MaterIals and Methods
Specimens of amniotic fluid were collected in the course of normal patient care and prepared and analyzed as described previously (10). All fluids were centrifuged at 1000 x g for 10 mm before analysis or storage of the supernatant fluid at -20 #{176}C. On thawing, the supernates were not recentrifuged; any particles that had formed in the freezing and thawing process were suspended evenly throughout the fluid before sampling for analysis. PG and "pseudo PG" were purified as follows: A pool of amniotic fluid that had been selected for large changes in apparent PG by prechromatography (10) was first extracted and chromatographed in replicate lanes across a large chromatography plate (Whatman no. 4855-821, ASP cat. no. C5498-57; American Scientific Products, Houston, TX 77041) by the thin-layer chromatographic system of Touchstone et a!. (11) . The two outermost lanes, the first containing synthetic PG standard and the next the amniotic fluid pool, were broken off the plate and the phospholipids stained with cupric acetate reagent. This treated strip was then used to locate the region of the unstained plate containing PG and pseudo PG. The silica in that region was scraped from all the remaining lanes and extracted three times with a mixture of equal volumes of methanol and chloroform. That extract, containing PG and pseudo PG, was evaporated. The residue was dissolved in chloroform and chroniatographed with our prechromatography development sequence (10) in all lanes of another plate. Treating the marker lanes as described above guided us in scraping the strips of silica containing only PG or pseudo PG, respectively. . Cases in which sepsis was apparent or suspected were eliminated from the study because their pulmonary surfactant status could not be assessed reliably. Table 1 shows, for 735 consecutively analyzed amniotic fluids, the frequency with which PG was detected in amniotic fluid within discrete ranges of LSR. There is a clear lack of coincidence of the LSR threshold of maturity of 2.0 with the uniform detection of PG (PG/sphingomyelin ratio 0.05; actual PG concentration depends on degree of saturation). The point where PG is detected in 50% of the fluids occurs between LSR 2.5 and 3.0, and PG is not uniformly detected until the LSR exceeds 4.5, well beyond a reasonable LSR threshold value for maturity. This relationship predicts that many fluids in which PG cannot be detected will be associated with the absence of respiratory difficulty. Table 2 shows the clinical outcomes of the 305 cases where delivery took place within 72 h of specimen collection and without sepsis. There was no respiratory difficulty in 42% of the cases where the LSR was <2.0; this is a significant but commonly reported proportion (2) . We screened these cases to assess the possible role of steroid administration in creating this pattern [such therapy accelerates surfactant production without being reflected in the phospholipid pattern in the amniotic fluid (15) ] and found that only nine of forty-five (20%) of the patients with LSR <2.0 but no RDS had been given glucocorticoids. We concluded that steroid administration was not a major factor in the false prediction of disease in this large group.
Results

LSR Correlation
Clinical Outcomes
Detection of PG did effectively rule out RDS, but PG was detected only 9% of the time when the LSR was "immature." The false-immature prediction rate of the LSR value alone was decreased by additional consideration of PG, but only from 42% to 40%. There were no respiratory problems of any kind associated with 58% of the 103 fluids lacking PG or in 84% of.the 43 PG-negative cases where the LSR was 2.0. Moreover, in the latter group, transient t.achypnea was the only respiratory problem observed. In the study group where the LSR was 2.0, consideration of the presence or absence of PG did not improve the predictivity of the analysis for RDS. A slightly greater frequency of transient tachypnea occurred in this group where PG was not detected. Indeed, the only group seen here to benefit from the addition of the PG analysis is that small number of cases where the LSR was slightly <2.0 but detection of PG correctly predicted a mature outcome.
Thin-Layer Chromatography Validation
Because the fluids in which we did not detect PG represented a somewhat larger percentage than that reported originally by Haliman eta!. Of the three systems, only that using the prechro- (2) , showed a somewhat greater frequency of detection of PG than we observed: PG was detected in 25% of the cases with LSR <2.0 (n = 57), whereas we found PG in only 9% of this group of 66 flUids. Further, in cases with an LSR <2.0 that lacked PG, they observed a 91% incidence of RDS, where we found only a 35% incidence. Both these discrepancies are consistent with the idea that their assay was somewhat more sensitive for PG, perhaps owing to different detection and quantification methods. But other differences-in patient population or scoring of RDS, for example--could also be contributing factors.
Large variations between reports of the observed presence of PG in amniotic fluid still exist. Table 3 shows several indices of the observed frequencies of detection and the predictive significance of PG in amniotic fluid by thin-layer chromatography, as taken from published reports. Both the frequency of detection of PG and its predictive significance vary considerably from study to study, and patterns in these data suggest large differences in sensitivity of the methods for PG.
The prechromatography step we introduced in the thinlayer chromatography method to remove pseudo PG from PG could have decreased the sensitivity of detection of PG in our assay by removing a fraction of PG that was detected in the earlier reports based on two-dimensional thin-layer chromatography.
The analytical data shown ensure that this is not the case; instead, the pseudo PG that comigrated with PG in the Helena method was also removed by twodimensional chromatography.
Where PG is reported at very high frequency in the general population, the contradictory presence of PG when LSR is not mature is also frequent. For example, in reports (5,6) in which PG was present in 89% and 93% of the overall fluids, PGwas also detected in 51% and 72% of the cases when LSR was not mature. 
Identifiable Methodological Biases between Studies
In conditions of temperature and time for the precipitation or wash of the dried phospholipids with acetone, a step not used in the initial report on PG in amniotic fluid (1) but implemented in the later study (2) . Other analytical details usually not included in these reportsbut which may be important to sensitivity for detecting PG include the performanceof the densitometer as influenced by beam width relative to spot width, the rate at which the plates are brought to the final temperature (21) , and the inclusion or exclusion of a recentrifugation step for the specimens after freezing and thawing.
Sulfuric acid, ammonium sulfate, and cupric acetate, as detection reagents, have well-documented differences in sensitivity for various degrees of saturation of the fatty acid side-chains of the phospholipids (11,22,23) .
This variation makes the definition of sensitivity for PG by thin-layer chromatography meaningless unless one uses pure phospholipids whose saturation is equivalent to that of the pulmonary surfactant phospholipids, which are 60% fully saturated and 33% singly unsaturated (24) .
Methods also vary with regard to specific interferences. Although some (24-26) have reportedthat meconium does not interfere in their methods for determining PG, a colorreactive substance in meconium that couldbe mistaken for PG has been recognized in our system (data not shown).This band, more diffuse than PG, is usually associatedwith visibly green-tinged fluids, but it presents a potential for falseidentification of PG. In some systems, components in blood may also mimic PG (27) , although in our system and others (28) thisis not the case.
Variation in results in different studies may be introduced by important differences in specimen handling that influence the actual concentration of PG, independent of analytical methodology. The particulate nature of the pulmonary surfactant complexes that carry PG (29) , balanced against the need to remove cellular and particulate interferents, has long been recognized as a complication in the analysis (17) and is a potential source of variability between laboratories for PG methods that involve centrifugation.
The Potential for Biological Bias among Study Populations
Differences in the frequency of detection of PG in maternal disease states have been reported (30) , and differences in patient populations could confuse interstudy data. In In 1979, Bustoset al. (32) concluded from studies of seven diabetic patients that PG production was accelerated relative to gestational age in diabetics in classes D, F, and R. A second report (33) by that group indicated that diabetics of classes B, C, D, F, and R (n = 177) were indistinguishable from normals but, rather, that PG was delayed in class-A diabetics (n = 43).A thirdreport (34) described delays in PG production in all classes of diabetics, especially B, C, and D (n = 74), with LSR used as an index of timing. The trend of delayed production of PG relative to LSR in diabetics was reportedmore recently as well (8, 25) , but others failed to confirmdifferences in timing of its appearance in diabetics (35). In contrast to the widely cited findings of Robert et al. (36) , the increased frequency of RDS for diabetic populations has also not been uniformly observed (37) . This failure to reproduce previously documented phenomena may reflect improved clinical management of diabetics (37) . Alternatively, other biological variations in the patient populations-gestational age distribution, gender (38), or stressful conditions such as maternal hypertension Of the 43 predictive cases in our study with a mature LSR but no PG, only 9% were diabetic; thus our observation is clearly not ascribable to delayed PG production by infants of diabetic mothers. We have not separated our diabetic patients for probability calculations because of the questionable basis in the literature for making such a difference and the relatively small sizeand low statistical power in our population.
The Importance of Sensitivity or Definition of the PG Signal
Definition of a "positive" PG has varied among studies and represents another major procedure-dependent aspect of the detection of PG. The original expression of PG in amniotic fluid was as a percentage of the total lipid phosphorus determined by measuring and summing allthe major phospholipids afterchromatography (1). A transition to the more convenient approach of quantification from densitometry, where the detection method is not phosphate-specific, requiredsummation of the lipid signals for the known phospholipids but still allowed expression of PG as a proportion of the total major phospholipids (2) . Remarkably, given that the two assay principles are totally different, the final percentageswere nearly equivalent, and in one report, they were averaged together for the final result (34) . The percentage scoredas PG-positive by this approach is usually 2-3% of the total lipids or phospholipids, depending on the detection method (2, 8) . To avoid the analytical uncertainty introduced by identifying and quantifyingfive distinct species of phospholipids simply to represent the concentration of PG, we chose to represent the data in a different form. PG was expressedhere as a densitometric ratio to sphingomyelin, analogous to the LSR, as was done by others (6,39,40, 41). We considered PG "positive" when the PG/sphingomyeha ratio was 0.05, which was chosen because it is practically equivalent to the point at which a PG band can be seen on the thin-layer chromatography plate. That the "appearance" of PG by these methods is equivalent to the onset of pulmonary maturation is challenged by data from highly sensitive enzymatic methods. Such data replace the older concept with a pattern of low concentrations of PG being present in amniotic fluid long before maturity,but increasing rapidly at the time the amount of surfactant becomes adequate (see below). That perspective would account for the variable and method-dependent data on the "presence" of PG reported with thin-layer chromatography. Further, one might therefore predict that if the sensitivity (detection limit) of a given method were the same as the concentration of PG that corresponds to lung maturity, this would simply be a coincidence.
Current Perspective of the "Presence" of PG
Thin-layer chromatographic methods with staining or charring and quantification by densitometry or planimetry vary in their sensitivities for PG and other phospholipids and give a wide range of results. Therefore, they cannot provide reference data to define the onset of PG production. The most sensitive and specific thin-layer chromatographic assay of PG has involved analysis for organic phosphate after recovery and extraction with organic solvents of the phospholipid species from the chromatography plate. So measured,as little as 0.5 mg PG per liter can be detected in amniotic fluid (16). This method eliminatesdependence on the degree of side-chain saturationseen with thin-layer chromatography staining or charringand also avoids interference by the many components of amniotic fluid that react with the visualization methods but do not contain phosphorus. The limitation of the phosphorus analysis method is that one may not totally recover one single chemicalspecies (spot) from the plate without including other compounds from the background, when a visualdetection method that is not itself sensitive to phosphorus is used as the guide.
Recently developed enzymatic assays for PG in amniotic fluid offer a potentially sensitive and specific reference method for the uniform study of this analyte. The assay of Farquharson et al. (42) , designed to rigorously remove endogenous glycerol, subjects the standards to the steps of analysis in which significant losses were shown to occur. The sensitive two-dimensional thin-layer chromatographic method of Whittleet al. (6) (Table 3 ) used in the evaluation of this enzymatic method was negative for PG in every case in which PG also was undetected by the enzymatic assay. On the other hand, the enzymatic assaydetected PG in more than half the samples in which thin-layer chromatography failed to detect it, but at concentrations generally <1 mg/L (expressed in terms of dipalmitoyl PG). In almost all cases, values for PG were >1 mg/L by enzymatic assay when the thin-layer chromatography result was positive. These data indicate that PG is indeed present in amniotic fluid at a time when, with traditional assays, it was regarded as "absent."
Concernsover the specificity of different enzymatic methods have been raised, particularly in regard to assays that indicate several-fold this much PG at all times through gestation (43, 44) . A recent report (45) showed that the glycerol concentration in amniotic fluid may be 10-to 20-fold as greatas that of PG, and may well be responsible for the high concentrations of PG in amniotic fluid reported in some early studies. This conclusion would favor the lower PG concentrations reportedby Farquharson et al. (42), after rigorous removal of glycerol. The latter workers reported the presence of PG very early in gestation but at concentrations too low to be detected by thin-layer chromatographic methods.
The clinical significance of the qualitative detection of PG by sensitive methods such as enzymatic assays or immunoassay (46) willdepend on the particular assay'sdetection limits, just as it does with the various thin-layer chromatographic assays. Use of quantitative methods, in contrast, will allow concentrations of PG to be determined that actually correspond to the onset of fetal lung maturity.
Conclusion
Our data, considered together with previous reports and the known sources of variability in PG determination, make it clear that current routine methods for detecting PG in amniotic fluid by thin-layer chromatography cannot be considered absolute or equivalent.
Data collected by thinlayer chromatographic methods, designed primarily to be practical in the clinical laboratory, should be viewed not as researchdata for defining the correlation of amniotic fluid phospholipids with clinical outcomes. Rather, such data constitute the controlled data base needed to define the specific performanceof a thin-layer chromatographic system in predicting disease.
The potential for confusion from generalizing data on the "presence" of PG as if it were method-independent (e.g., ref. 1, 10,25,39,40,  48, 49) . The College of American Pathologists' proficien survey regularlyshows that --5% of the participants reps PG when it is not present, or reportits absence when it is i factpresent-further evidence of the significance of th heterogeneity of methods for PG in use in clinical labora tories today.
We think that simultaneous determination of the IS and PG remains the soundest means of evaluating fe pulmonary maturity, by providing two independent pi of information whose extreme inconsistency may refi analytical interferences.
In such a case, the presence o CLINICAL CHEMISTRY, Vol. 34, No. 10, 1988 1981 meconium (see above), bacterial colonization as a source of PG (50), or interference with the LSR by blood (51) can be considered as possible causes of variance, allowing one resultor the other to be considered the more reliable. Our data define the predictive responseof this analytical system in a group of unselectedcases. From these results, we recommend a primary reliance on the LSR with this system, except when an immature LSR is contradicted by the detection of PG; in such cases,the PG, given the threshold of sensitivity of this assay, predictsfetal lung maturityreliably.
